Furthermore, there is great encouragement of studies on bioactives of a natural origin that act as DPP-4 inhibitors since they possess significant antioxidant properties and their use may be an effective strategy for overcoming oxidative stress in pancreatic β-cells and other important tissues, in parallel to treating diabetes [25]. This evidence concerns the gene DPP4 and diabetes mellitus.